Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China · Delayed Price · Currency is CNY 9.70
-0.12 (-1.22%)
Sep 18, 2025, 2:45 PM CST
SHE:002550 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 431.29 | 356.03 | 181.86 | 323.41 | 181.08 | -132.02 | Upgrade |
Depreciation & Amortization | 62.45 | 64.61 | 69.22 | 64.76 | 69.43 | 70.25 | Upgrade |
Other Amortization | 4.94 | 5.27 | 3.75 | 3.55 | 5.67 | 3.39 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -25.35 | -57.59 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | -57.41 | 0.04 | 7.77 | 0.24 | 0.46 | 1.6 | Upgrade |
Loss (Gain) From Sale of Investments | -18.36 | -13.89 | -8.83 | 3.82 | -0.64 | -16.03 | Upgrade |
Provision & Write-off of Bad Debts | 6.04 | 6.04 | -19.02 | 15.3 | -52.68 | 5.04 | Upgrade |
Other Operating Activities | -95.46 | -101.48 | 19.11 | -46.62 | 6.11 | 390.89 | Upgrade |
Change in Accounts Receivable | -42.54 | -12.26 | 420.4 | -165.9 | 55.37 | 49.78 | Upgrade |
Change in Inventory | 95.01 | 172.11 | -77.46 | -136.12 | -84.79 | -73.03 | Upgrade |
Change in Accounts Payable | -32.36 | 24.09 | -50.63 | -83.14 | -86.65 | 82.57 | Upgrade |
Change in Other Net Operating Assets | -0.62 | -0.62 | 1.98 | 4.37 | 4.12 | 4.07 | Upgrade |
Operating Cash Flow | 376.35 | 514.71 | 533.33 | -71.47 | 103.56 | 317.28 | Upgrade |
Operating Cash Flow Growth | -47.00% | -3.49% | - | - | -67.36% | 96.40% | Upgrade |
Capital Expenditures | -128.45 | -90.64 | -100.33 | -70.99 | -90.37 | -62.53 | Upgrade |
Sale of Property, Plant & Equipment | - | 13.5 | 32.3 | 0.11 | 0 | 0.02 | Upgrade |
Cash Acquisitions | - | - | - | -1.67 | - | - | Upgrade |
Investment in Securities | -232.15 | -232.15 | -108.5 | -121.08 | 177.22 | 489.88 | Upgrade |
Other Investing Activities | 201 | -13.94 | 1.43 | 3.65 | 8.43 | 32.17 | Upgrade |
Investing Cash Flow | -159.59 | -323.23 | -175.1 | -189.98 | 95.28 | 459.53 | Upgrade |
Short-Term Debt Issued | - | 4.69 | 435.51 | 461.27 | 124.95 | 326.15 | Upgrade |
Total Debt Issued | 4.69 | 4.69 | 435.51 | 461.27 | 124.95 | 326.15 | Upgrade |
Short-Term Debt Repaid | - | -40.1 | -480 | -440 | -77.43 | -628.54 | Upgrade |
Total Debt Repaid | -5.22 | -40.1 | -480 | -440 | -77.43 | -628.54 | Upgrade |
Net Debt Issued (Repaid) | -0.53 | -35.41 | -44.49 | 21.27 | 47.52 | -302.39 | Upgrade |
Issuance of Common Stock | - | - | - | 144.9 | - | 171.84 | Upgrade |
Repurchase of Common Stock | -140.77 | -140.77 | -30.09 | - | -0.19 | -0.3 | Upgrade |
Common Dividends Paid | -150.71 | -151.52 | -158.79 | -155.16 | -151.51 | -313.62 | Upgrade |
Other Financing Activities | 143.77 | 3 | 42.5 | - | - | - | Upgrade |
Financing Cash Flow | -148.24 | -324.71 | -190.87 | 11.02 | -104.17 | -444.47 | Upgrade |
Foreign Exchange Rate Adjustments | -1.32 | -1.85 | -1.6 | 41.89 | 7.39 | -18.6 | Upgrade |
Net Cash Flow | 67.2 | -135.07 | 165.76 | -208.55 | 102.06 | 313.74 | Upgrade |
Free Cash Flow | 247.9 | 424.07 | 433 | -142.46 | 13.19 | 254.74 | Upgrade |
Free Cash Flow Growth | -59.75% | -2.06% | - | - | -94.82% | 318.51% | Upgrade |
Free Cash Flow Margin | 16.18% | 27.79% | 23.87% | -6.18% | 0.70% | 15.28% | Upgrade |
Free Cash Flow Per Share | 0.20 | 0.33 | 0.33 | -0.11 | 0.01 | 0.21 | Upgrade |
Cash Income Tax Paid | 150.65 | 150.65 | 45.16 | 26.55 | 81.87 | 79.15 | Upgrade |
Levered Free Cash Flow | -57.45 | 334.4 | 344.34 | -216.74 | -40.56 | 609.25 | Upgrade |
Unlevered Free Cash Flow | -56.59 | 335.27 | 348.04 | -213.46 | -39.53 | 614.53 | Upgrade |
Change in Working Capital | 42.87 | 198.09 | 304.81 | -378.36 | -105.88 | -5.84 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.